| Balance Sheets | 2025-06-30 | |||
|---|---|---|---|---|
| Cash | 92,700 | |||
| Insurance receivable | 0 | |||
| Investment in equity securities | 387,851 | |||
| Prepaids and other assets | 566,081 | |||
| Total current assets | 1,046,632 | |||
| Property and equipment, net | 367,843 | |||
| Deposits and other assets | 0 | |||
| Definite life intangible assets, net | 14,994 | |||
| Software platform | 143,000 | |||
| Trademarks | 8,000 | |||
| Goodwill | 5,963,000 | |||
| Operating lease right-of-use assets | 687,371 | |||
| Total other assets | 6,816,365 | |||
| Total assets | 8,230,840 | |||
| Accounts payable trade | 12,555,839 | |||
| Accrued expenses | 5,843,069 | |||
| Other current liabilities | 378,282 | |||
| Contingent consideration liability | 630,000 | |||
| Convertible notes payable | 245,000 | |||
| Current portion of operating lease liabilities | 313,047 | |||
| Notes payable | 3,580,525 | |||
| Notes payable related parties, net | 5,610,372 | |||
| Total current liabilities | 29,156,134 | |||
| Operating lease liabilities, net of current portion | 424,547 | |||
| Total non-current liabilities | 424,547 | |||
| Total liabilities | 29,580,681 | |||
| Common stock, par value 0.0001, 350,000,000 shares authorized, 177,392,907 shares issued and outstanding at june 30, 2025 158,452,644 shares issued and outstanding at june 30, 2024 | 17,741 | |||
| Additional paid-in capital | 478,280,146 | |||
| Accumulated deficit | -510,462,570 | |||
| Accumulated other comprehensive (loss) | 10,814,842 | |||
| Total stockholders equity (deficit) | -21,349,841 | |||
| Total liabilities and stockholders equity (deficit) | 8,230,840 | |||
Lunai Bioworks Inc. (RENB)
Lunai Bioworks Inc. (RENB)